Experienced non-executive director and global executive leader with a deep knowledge of life-sciences, digital technology, manufacturing, supply chain and innovation.
Combines strategic leadership, analytical skills and experience of working in life-sciences and IT with experience of corporate governance, financial control and regulation to deliver value to stakeholders in a fast-changing business environment.
NED & Board Advisory Experience
- Medicines and Healthcare Products Regulatory Agency
- NED
- Interim Co-Chair 2023-2024
- Chair of Organisation Development and Remuneration Committee
- Member of Audit and Risk Committee
- High Value Manufacturing Catapult
- NED
- Chair of Audit and Risk Committee
- Cambridge Judge Business School
- Member of Advisory Board
- Chair of the first remuneration committee for the business school
- The Guinness Partnership Limited
- NED
- Chair of Safety Committee
- Member of Audit & Risk Committee
- Henley Women’s Regatta
- Deputy Executive Chair with responsibility for revenue generation
Skills
Industry Experience
- Pharmaceuticals and Life Sciences
- AstraZeneca Roles– 27 years
- Global IT Leader at AstraZeneca
- VP Global Supply Chain IT
- VP Global IT compliance and cyber security
- Global Supply Director
- Strategic design and roll-out of global supply chain processes
- Head of Oncology Supply Chains
- Head of Mature Brands Supply Chains
- UK Facilities Management Transformation and Operations Leader
- Established UK facilities management through integration of different departments
- Developed a long-term site development plan for the AstraZeneca R&D campus
- Manufacturing and Technology Leadership
- Responsibility for manufacturing operations, commissioning and maintenance of plant
- Responsibility for engineering operations
- Regulatory approval for new products and processes
- Global IT Leader at AstraZeneca
- Biotech and Life Sciences SME’s
- Advisor to Duke Steet Bio who are currently developing oral oncology treatment and in Phase 1 Trials
- Founded Fennix Pharmaceuticals to develop a novel oral chemotherapy treatment for colorectal cancer. Was unable to secure the licence as licensor went into liquidation.
- Ad-hoc advisor to several early-stage biotech companies.
- Academia
- Knowledge of university management processes
Team development
- Social Housing
- Knowledge of grant processes, social housing governance, development strategy, operations and customer services
- Care businesses and its challenges
Skills
- Business strategy development and change implementation
- Regulation mainly in healthcare but also social housing
- Governance and risk management
- Operations and change management
- Manufacturing technology and supply chain management
- Digital and IT technology
- Cyber security
- Financial oversight
- Business Transformation
- Developing high performing teams
- Broad knowledge of multiple business domains and the ability to listen, learn and help businesses develop new solutions
- Mentoring and coaching
- Sports Event Management (rowing and running)
Credentials
- MA Engineering Science (University of Cambridge)
- Chartered Engineer (Institution of Mechanical Engineers)